<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39407116</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Longitudinal investigation of a single variant SARS-CoV-2-outbreak in the immunologically naïve population of Ulvik, Norway.</ArticleTitle><Pagination><StartPage>1161</StartPage><MedlinePgn>1161</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1161</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-024-09856-2</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To perform an extensive investigation of the clinical features and long-term complications among the n = 134 adults and children with nucleic acid amplification test (NAAT) verified SARS-CoV-2-infection in the immunologically naïve population of Ulvik, Norway, during the single variant B.1.1.7 outbreak in late January through February 2021.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Every infected person regardless of whether symptoms of COVID-19 were present was invited to answer a web-based questionnaire at two- and seven months after testing positive. The period from initial infection to the first questionnaire was assessed retrospectively, and the time points at two- and seven months were assessed prospectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 87 of 134 (65%) NAAT-positive persons answered the first questionnaire, of which 35/87 (40%) were children, and 74 of 87 (85%) answered the second questionnaire. Children experienced symptoms less often than adults during the acute phase of infection (51% (18/35) versus 81% (42/52) (p = .004)). At two-months follow-up 88% (53/60) of participants with symptoms during the acute phase, including all children, reported no longer having symptoms. Among those with persisting symptoms at seven months, fatigue (18/25) and insomnia (16/24) were common.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In an immunologically naïve population infected with the SARS-CoV-2 B.1.1.7 variant, the clinical features of acute phase symptoms were similar to previous studies. Children underwent asymptomatic infection more often than adults, and adults more often experienced persisting symptoms. Insomnia and fatigue were common complaints among those with persisting symptoms seven months after infection.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mortensen</LastName><ForeName>Nicolay</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway. nicolay.mortensen@helse-bergen.no.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Haukeland University Hospital, Bergen, Norway. nicolay.mortensen@helse-bergen.no.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Norwegian Advisory Unit for Antibiotic Use in Hospitals, Bergen, Norway. nicolay.mortensen@helse-bergen.no.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wensaas</LastName><ForeName>Knut-Arne</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Research Unit for General Practice, NORCE Norwegian Research Centre, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solem</LastName><ForeName>Unni</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Ulvik municipality, Ulvik, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivertsen</LastName><ForeName>Audun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grewal</LastName><ForeName>Harleen M S</ForeName><Initials>HMS</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Science, Bergen Integrated Diagnostic Stewardship Cluster, Faculty of Medicine, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rortveit</LastName><ForeName>Guri</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ulvestad</LastName><ForeName>Elling</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Science, Bergen Integrated Diagnostic Stewardship Cluster, Faculty of Medicine, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Litleskare</LastName><ForeName>Sverre</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research Unit for General Practice, NORCE Norwegian Research Centre, Bergen, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009664" MajorTopicYN="N" Type="Geographic">Norway</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Complete outbreak</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Insomnia</Keyword><Keyword MajorTopicYN="N">Long-term symptoms</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39407116</ArticleId><ArticleId IdType="pmc">PMC11481362</ArticleId><ArticleId IdType="doi">10.1186/s12879-024-09856-2</ArticleId><ArticleId IdType="pii">10.1186/s12879-024-09856-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Director-General’s opening. remarks at the media briefing on COVID-19–11 March 2020 [Internet]. [cited 2023 Jun 28]. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020</Citation></Reference><Reference><Citation>Hu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19:141–54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ, Long COVID. Major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;1–14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of long covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. Eclinicalmedicine. 2023;55:101762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Solem U. Ei lita verd [Internet]. Utposten. [cited 2023 Feb 8]. https://www.utposten.no/journal/2021/4/m-275/Ei_lita_verd</Citation></Reference><Reference><Citation>Norway S. 11342: Population and area, by region, contents and year [Internet]. [cited 2023 Feb 8]. https://www.ssb.no/en/statbank/table/11342/tableViewLayout1/</Citation></Reference><Reference><Citation>Sivertsen A, Mortensen N, Solem U, Valen E, Bullita MF, Wensaas K-A et al. Comprehensive contact tracing during an outbreak of alpha-variant SARS-CoV-2 in a rural community reveals less viral genomic diversity and higher household secondary attack rates than expected. mSphere. 2024;e0011424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11351100</ArticleId><ArticleId IdType="pubmed">39109863</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res. 1993;37:147–53.</Citation><ArticleIdList><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>Wensaas K-A, Langeland N, Hanevik K, Mørch K, Eide GE, Rortveit G. Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study. Gut. 2012;61:214.</Citation><ArticleIdList><ArticleId IdType="pubmed">21911849</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessely S. The epidemiology of chronic fatigue syndrome. Epidemiol Rev. 1995;17:139–51.</Citation><ArticleIdList><ArticleId IdType="pubmed">8521932</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallesen S, Bjorvatn B, Nordhus IH, Sivertsen B, Hjørnevik M, Morin CM. A New Scale for Measuring Insomnia: the Bergen Insomnia Scale. Percept Motor Skill. 2008;107:691–706.</Citation><ArticleIdList><ArticleId IdType="pubmed">19235401</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole TJ, Lobstein T. Extended international BMI cut-offs. Pediatr Obes. 2012;7:284–94.</Citation><ArticleIdList><ArticleId IdType="pubmed">22715120</ArticleId></ArticleIdList></Reference><Reference><Citation>Buitrago-Garcia D, Salanti G, Low N. Studies of prevalence: how a basic epidemiology concept has gained recognition in the COVID-19 pandemic. BMJ Open. 2022;12:e061497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9620521</ArticleId><ArticleId IdType="pubmed">36302576</ArticleId></ArticleIdList></Reference><Reference><Citation>Millard LAC, Fernández-Sanlés A, Carter AR, Hughes RA, Tilling K, Morris TP, et al. Exploring the impact of selection bias in observational studies of COVID-19: a simulation study. Int J Epidemiol. 2022;52:44–57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9908043</ArticleId><ArticleId IdType="pubmed">36474414</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Hartman TC, olde, Rosmalen JGM, Initiative LCR. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400:452–61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy EB, Charifson M, Jehn M, Jensen EA, Vikse J. Prospective sampling bias in COVID-19 recruitment methods: experimental evidence from a national randomized survey testing recruitment materials. Bmc Med Res Methodol. 2022;22:251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9510455</ArticleId><ArticleId IdType="pubmed">36162985</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesquita Rda, Junior R, Santana LCFS, Oliveira FMS, de Alcântara TF, Arnozo RC. Clinical manifestations of COVID-19 in the general population: systematic review. Wiener Klinische Wochenschrift. 2021;133:377–82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7689634</ArticleId><ArticleId IdType="pubmed">33242148</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson WM, Price JC, Eisler L, Sun LS, Lee JJ. COVID-19 in Pediatric patients: a systematic review. J Neurosurg Anesthesiol. 2022;34:141–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">34870638</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole-Wright K, Guennouni I, Sterry O, Evans RA, Gaughran F, Chalder T. Fatigue outcomes following COVID-19: a systematic review and meta-analysis. Bmj Open. 2023;13:e063969.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10151247</ArticleId><ArticleId IdType="pubmed">37185637</ArticleId></ArticleIdList></Reference><Reference><Citation>Loge JH, Ekeberg Ø, Kaasa S. Fatigue in the general Norwegian population normative data and associations. J Psychosom Res. 1998;45:53–65.</Citation><ArticleIdList><ArticleId IdType="pubmed">9720855</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvakumar J, Havdal LB, Drevvatne M, Brodwall EM, Berven LL, Stiansen-Sonerud T, et al. Prevalence and characteristics Associated with Post–COVID-19 Condition among Nonhospitalized adolescents and Young adults. Jama Netw Open. 2023;6:e235763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10064252</ArticleId><ArticleId IdType="pubmed">36995712</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG-I, Brokstad KA, Zhou F, Linchausen DW, Hansen B-A, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27:1607–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorvatn B, Rørtveit G, Rebnord I, Waage S, Emberland KE, Forthun I. Self-reported short and long sleep duration, sleep debt and insomnia are associated with several types of infections: results from the Norwegian practice-based research network in general practice – PraksisNett. Sleep Med: X. 2023;5:100074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10200965</ArticleId><ArticleId IdType="pubmed">37223609</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva E, Terraneo M, Lucchini M, Gerosa T. The prevalence of insomnia in different COVID-19 policy phases: longitudinal evidence from ITA.LI – Italian lives. BMC Public Health. 2022;22:1657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9434520</ArticleId><ArticleId IdType="pubmed">36050669</ArticleId></ArticleIdList></Reference><Reference><Citation>Halsøy Ø, Johnson SU, Hoffart A, Ebrahimi OV. Insomnia symptoms in the General Population during the COVID-19 pandemic. Front Psychiatry. 2021;12:762799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8602186</ArticleId><ArticleId IdType="pubmed">34803771</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin CM, Bjorvatn B, Chung F, Holzinger B, Partinen M, Penzel T, et al. Insomnia, anxiety, and depression during the COVID-19 pandemic: an international collaborative study. Sleep Med. 2021;87:38–45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8425785</ArticleId><ArticleId IdType="pubmed">34508986</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>